Vertex Pharmaceuticals Inc. sell Robert W. Baird
Start price
31.01.24
/
50%
€400.05
Target price
31.01.25
€299.00
Performance (%)
10.29%
End price
01.02.25
€441.20
Summary
This prediction ended on 01.02.25 with a price of €441.20. The prediction closed with a disappointing performance of 10.29%. Robert_W__Baird has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Sell. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | -7.666% | -7.666% | 3.682% |
| iShares Core DAX® | -2,68 % | 4,26 % | 2,12 % |
| iShares Nasdaq 100 | 0,73 % | 5,80 % | 34,20 % |
| iShares Nikkei 225® | -0,73 % | 9,32 % | 61,30 % |
| iShares S&P 500 | 1,17 % | 5,48 % | 24,75 % |
Comments by Robert_W__Baird for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Robert_W__Baird gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was downgraded by analysts at Robert W. Baird from a "neutral" rating to an "underperform" rating. They now have a $325.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat
Current prediction by Robert_W__Baird for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€464.00
07.07.26
07.07.26
€306.01
07.07.27
07.07.27
-8.36%
10.07.26
10.07.26
